5 best Amazon deals up to 88% off, plus 20 more rare discounts on Apple, Nespresso, Shark and more
While Prime Day, Boxing Day and Black Friday may be its best-known sales, Amazon Canada's Deals Store is loaded with discounts 365 days a year. Right now, Amazon shoppers can save hundreds on name-brand smartwatches (like an Apple Watch Series 10), electronic toothbrushes and coffee machines.
But, like all Amazon deals, these prices won't last for long, so if you're looking to save on personal care essentials or new tech, the clock is ticking to save. Below, we've gathered some of the best and most exciting Amazon Canada deals available right now, including a handful that are 70 per cent off or more. Keep scrolling to shop the sale.
Shop all deals at Amazon
20 other really good Amazon deals to shop right now
Best Amazon tech deals
Save 50%: JBL Vibe Flex True Wireless Earbuds (shop for $50 $100)
84% off: 1.27" HD Touchscreen Fitness Tracker (shop for $66 $400)
Take 17% off: Apple Watch Series 10 (shop for $489 $589)
21% off: Apple 2025 MacBook Air 13" Laptop (shop for $1,100 $1,399)
Save 31%: TP-Link AC1900 WiFi Extender (shop for $55 $80)
Best Amazon kitchen deals
Save 40%: Cold Press Juicer (shop for $120 $200)
Take 27% off: Smeg 50's Retro Style Electric Kettle (shop for $220 $300)
Save 36%: Chefman Air Fryer (shop for $70 $110)
57% off: Contigo Streeterville 40 oz Tumbler (shop for $20 $47)
Take 44% off: Nespresso Vertuo Next Coffee and Espresso Machine (shop for $129 $229)
Best Amazon home & living deals
Save 20%: Tide PODS Free & Gentle Laundry Detergent Soap Pacs (shop for $20 $25)
46% off: 50-Piece Large Food Storage Containers (shop for $35 $65)
Take 88% off: YKYI Electric Spin Scrubber (shop for $50 $400)
Save 25%: Swiffer PowerMop Multi-Surface Mop Kit (shop for $30 $40)
21% off: Charmin Ultra Strong Toilet Paper (shop for $28 $35)
Best Amazon beauty & personal care deals
Save 50%: Oral-B Pro Limited Electric Toothbrush (shop for $60 $120)
29% off: Blood Pressure Machine (shop for $29 $41)
Save 15%: Shark FlexStyle Air Styling & Drying System (shop for $280 $330)
20% off: Triple Strength Omega 3 Fish Oil (shop for $31 $39)
Take 40% off: RENPHO Body Fat Scale (shop for $30 $50)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Revenue Growth: 6% increase for the quarter and 5% for the fiscal year. Cash from Operations: $30 million for the quarter and $71 million for the fiscal year. Gross Margin Expansion: 370 basis points for the quarter and 280 basis points for the year. EBITDA Margin: 8.5% for the fourth quarter and 7.7% for the fiscal year. Gross Profit: Increased to $25.4 million for the fourth quarter. Operating Cash Flow: $30.2 million for the quarter, a 55% improvement over the same period last year. Free Cash Flow: $64.5 million for the fiscal year. Capital Expenditures: $7.2 million for the fiscal year. Cash Position: Ended the year with $84.6 million in cash. Available Credit Facilities: Approximately $52 million available. Warning! GuruFocus has detected 4 Warning Signs with CSAN. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strattec Security Corp (NASDAQ:STRT) ended fiscal 2025 with strong sales growth and expanded margins. The company generated $30 million in cash from operations for the quarter and $71 million for the fiscal year. Revenue grew 6% in the quarter and 5% for the year, driven by strategic pricing initiatives and higher demand. Gross margin expanded by 370 basis points for the quarter and 280 basis points for the year. The company has a healthy cash position of $84.6 million and approximately $52 million available under revolving credit facilities. Negative Points The company faces ongoing tariff expenses, with an estimated annual cost increase between $5 million to $7 million. Higher labor costs in Mexico are impacting the company's financials. The fiscal year 2026 is expected to see lower North American automotive production, potentially affecting sales. The company is still in the early stages of its transformation process, with long-term changes needed. There is uncertainty in the market, which may impact the company's ability to maintain its current cash flow levels. Q & A Highlights Q: How far along is Strattec in its transformation process, and what does the future look like for this initiative? A: Jennifer Slater, President and CEO, stated that Strattec is still in the early stages of its transformation. While they have addressed much of the low-hanging fruit in fiscal year 2025, future transformation efforts will be more long-term in nature. Q: Is Strattec considering exiting or divesting any product lines as part of its transformation? A: Jennifer Slater mentioned that Strattec is refocusing its engineering efforts on products with more growth potential, such as power access products and digital key fobs, rather than crowded markets like the switch product line. Q: What is the outlook for Strattec's gross margins in fiscal 2026? A: Matthew Pauli, CFO, indicated that while fiscal 2025 ended with a 15% gross margin, fiscal 2026 is expected to see revenues down to flattish. However, they anticipate tailwinds from pricing actions and restructuring efforts, balanced by inflationary pressures and volume headwinds. Q: How does Strattec plan to utilize its substantial cash reserves, and what is considered an appropriate cash cushion? A: Jennifer Slater explained that the company is comfortable with its current cash position, which provides stability amid market uncertainties. They are focusing on transforming the business and will consider cash allocation for shareholder value once there is more market certainty. Q: What are Strattec's plans for new product offerings or revenue opportunities in the next three to five years? A: Jennifer Slater stated that Strattec is focusing on expanding its customer base within its current product portfolio, particularly in power access and digital key products, while also exploring opportunities with new customers. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
16 minutes ago
- Yahoo
BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLGO) has maintained its net stockholders' equity at around $6 million despite recent losses, showcasing effective capital management. The company has seen a significant increase in service revenues, rising from $300,000 to $1.2 million in the first half of the year. BioLargo Inc (BLGO) has successfully shipped its AEC unit to New Jersey, with validation work to be conducted by state and federal EPA, enhancing credibility. The company has raised $3.3 million in its subsidiary, Clyra Medical, indicating strong investor confidence in its potential. BioLargo Inc (BLGO) is pursuing a capital-conserving strategy by forming joint ventures for battery manufacturing, leveraging public funding and partnerships. Negative Points BioLargo Inc (BLGO) experienced a decline in revenue, with $3 million in the recent quarter compared to $5 million in the same period last year. The company faces uncertainty with its partner Ikigai and Pooph, impacting cash flow and financial forecasting. There is a significant delay in the commercialization of Clyra's wound care product, raising concerns about execution timelines. BioLargo Inc (BLGO) has increased debt obligations, primarily related to Clyra's preparation for product launch. The company is operating under financial pressure due to reduced cash flow from Pooph sales, necessitating cautious financial management. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BLGO. Q: Can you provide any additional insight into the challenges and successes to the barriers to entry for the salinity battery? A: Dennis Calvert, CEO, explained that the primary challenges include technical proof of claim, scaling up manufacturing, and regulatory hurdles. The company has achieved significant technical milestones and is working on scaling up production. Regulatory barriers are relatively low, focusing mainly on safety data and UL certification. The company is confident in its technology and is working towards proving its claims and securing partnerships. Q: Will BioLargo be funding the cost to build battery factories? Will you be involved in designing and building the factories? A: Dennis Calvert, CEO, stated that BioLargo will not be funding the factories directly. Instead, they will act as a vendor, providing engineering services, project management, and technology transfer. The factories will be financed through partnerships, public funding, and other financial arrangements, allowing BioLargo to focus on leveraging its core competencies. Q: What is the latest on New Jersey and the AEC project? A: Dennis Calvert, CEO, reported that the AEC unit has been shipped and is being set up in Lake Stockholm. The state and federal EPA will participate in validation work, which is crucial for future customer demonstrations. The company is excited about this significant milestone and will announce the go-live date soon. Q: How can you be so confident about Clyra given that it's taken so long? A: Dennis Calvert, CEO, expressed confidence in Clyra due to recent investments of $3.3 million and the technical prowess of their invention. The company is preparing for a significant product launch with strong partnerships in place. They aim to complete third-party testing and FDA paperwork by the end of the year, targeting a Q1 launch. Q: Do you have insight on Pooph's operations as far as advertising spend, the number of stores that they're in? A: Dennis Calvert, CEO, mentioned limited insight into Pooph's operations, making it difficult to forecast. However, he noted that Pooph had previously achieved a $50 million run rate and was in 40,000 stores. The company remains optimistic about Pooph's potential but is cautious due to uncertainties. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
16 minutes ago
- Yahoo
Marfrig Global Foods SA (MRRTY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...
Consolidated Net Revenue: BRL37.8 billion, up 8.6% year-over-year. Adjusted Managerial Consolidated EBITDA: BRL3 billion with a margin of 8%. Operating Cash Flow: BRL3 billion, 17% higher than Q2 '24. Net Income: BRL85 million, a 13% increase versus the same period last year. Leverage Ratio: Net debt to adjusted EBITDA at 2.71x, down from 3.38x a year ago. North America Net Sales: $3.3 billion, an increase of 5.3% versus last year. North America EBITDA: $25 million, 71.8% lower than last year with a margin of 0.8%. South America Sales Volume: 205,000 metric tons, up 7.8% from Q2 '24. South America Net Revenue: BRL4 billion, about 10% higher year-over-year. South America Adjusted EBITDA: BRL439 million, an increase of more than 31% from Q2 '24 with a margin of 10.9%. Exports from South America: Accounted for 55% of total revenue, with China representing 45% of exports. Free Cash Flow: Positive at BRL272 million after investments and financial expenses. Consolidated Net Debt: BRL37.6 billion, down 1.4% compared to Q1 2025. Dividend Payments: BRL2.5 billion paid in the past five years, with BRF paying BRL1.1 billion in 2024. Warning! GuruFocus has detected 8 Warning Signs with MRRTY. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Consolidated net revenue for Q2 2025 increased by 8.6% year-over-year, reaching BRL37.8 billion. Operating cash flow totaled BRL3 billion, marking a 17% increase compared to Q2 2024. Net income rose by 13% year-over-year, amounting to BRL85 million. Leverage ratio improved, with net debt to adjusted EBITDA decreasing from 3.38x to 2.71x. South America operations saw a 31% increase in adjusted EBITDA, driven by higher capacity and improved efficiency. Negative Points North American sales volume decreased by 5.6% compared to the previous year. EBITDA for North America operations fell by 71.8%, with a margin of only 0.8%. Cattle supplies are expected to remain tight, impacting capacity utilization across the industry. The company faces challenges with higher tariffs affecting exports from Brazil to the United States. Despite strong demand, advances in box beef prices lagged behind the surge in live cattle prices. Q & A Highlights Q: After the merger, what are BRF's main strategies initially? Will the focus be on capturing synergies or focusing more organically? A: Our main focus is on synergies. We have identified BRL800 million worth of synergies, which is a conservative estimate. We are confident in achieving these synergies as everything has been well mapped out. Additionally, listing in the US is on our radar to improve multiples and lower our cost of capital. The next six months will focus on synergy while preparing for international expansion. - Marcos dos Santos, Chairman of the Board Q: Regarding South America, despite export restrictions and American tariffs, is it expected to have a positive Q3 with improved margins? A: Yes, we expect a positive second half. We are not at full capacity yet, but we plan to grow 30% this year. Our feedlots have grown 26% compared to Q2 '24, improving quality and serving the European market better. Operational excellence and efficiency gains are expected to contribute positively. - Marcos dos Santos, Chairman of the Board Q: Is there room for operational efficiencies in North America to face the current cycle challenges? A: Yes, we expect more internal improvements that will benefit our bottom line. We are seeing signs of cattle retention, which will slow down marketing, but we don't expect it to be as dramatic as the last cycle. - Timothy Klein, CEO - North America Operations Q: How do you see international market prices and demand for South America in the second half? A: The main highlight is China, with an average price increase of 25% compared to Q2 2024. Demand and price outlook are favorable, especially with geographic diversification providing advantages. New markets like the Philippines and Indonesia offer profitability opportunities. - Rui Mendonca, CEO & Member of Board of Executive Officers Q: Could you elaborate on plans to deleverage and manage liabilities post-merger? A: The merger offers many opportunities for capital structure optimization. Both financial teams are working to extract benefits and gains. We have BRL23 billion worth of cash that can be used for liability management to reduce financial expenses. - Tang David, Chief Financial & Investor Relations Officer For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
